1. Academic Validation
  2. ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma

ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma

  • Leukemia. 2017 Jun;31(6):1470-1473. doi: 10.1038/leu.2017.94.
A Dzikiewicz-Krawczyk 1 2 K Kok 3 I Slezak-Prochazka 1 4 J-L Robertus 1 J Bruining 1 M M Tayari 1 B Rutgers 1 D de Jong 1 J Koerts 1 A Seitz 1 J Li 3 B Tillema 1 J E Guikema 5 I M Nolte 6 A Diepstra 1 L Visser 1 J Kluiver 1 A van den Berg 1
Affiliations

Affiliations

  • 1 Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • 2 lnstitute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
  • 3 Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • 4 Biosystems Group, Institute of Automatic Control, Silesian University of Technology, Gliwice, Poland.
  • 5 Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • 6 Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Figures